Table 1.
mtDNA content in tumor tissue | T/N ratio of mtDNA content | ||||
---|---|---|---|---|---|
n | Mean ± SD | P value* | Mean ± SD | P value* | |
Age (years) | |||||
| |||||
<40 | 56 | 592 ± 530 | 0.861 ± 0.561 | ||
40–49 | 103 | 588 ± 473 | 0.603 | 0.967 ± 0.7 | 0.817 |
50–59 | 77 | 574 ± 515 | 0.956 ± 0.92 | ||
≥60 | 57 | 577 ± 402 | 0.956 ± 0.849 | ||
| |||||
Tumor size (cm3) | (versus C) | (versus C) | |||
| |||||
A: ≤4.9 | 79 | 735 ± 412 | 4.06e − 07 | 1.088 ± 0.636 | 1.84e − 05 |
B: 5~14.9 | 66 | 574 ± 354 | 0.004 | 1.000 ± 0.556 | 0.002 |
C: 15–49.9 | 75 | 372 ± 248 | 0.696 ± 0.459 | ||
D: ≥50 | 53 | 535 ± 385 | 0.306 | 0.818 ± 0.553 | 0.258 |
| |||||
Grade | |||||
| |||||
0~I | 18 | 669 ± 412 | 0.995 ± 0.681 | ||
II | 125 | 506 ± 318 | 0.019 (versus 0~I) | 0.791 ± 0.531 | 0.827 (versus 0~I) |
III | 98 | 648 ± 432 | 0.383 (versus 0~I) 0.006 (versus II) |
1.128 ± 0.988 | 0.441 (versus 0~I) 0.033 (versus II) |
| |||||
ER | |||||
| |||||
Negative | 107 | 502 ± 405 | 0.103 | 0.810 ± 0.612 | 0.047 |
Positive | 157 | 573 ± 374 | 1.057 ± 1.059 | ||
| |||||
PR | |||||
| |||||
Negative | 100 | 494 ± 352 | 0.061 | 0.839 ± 0.633 | 0.059 |
Positive | 154 | 597 ± 384 | 1.034 ± 0.772 | ||
| |||||
ER/PR | |||||
| |||||
A:ER,PR both − or either + | 134 | 473 ± 316 | 0.005 | 0.837 ± 0.536 | 0.355 |
B: ER+/PR+ | 129 | 618 ± 381 | 0.930 ± 0.617 | ||
| |||||
Her2/neu receptor | |||||
| |||||
Negative | 56 | 444 ± 333 | 0.101 | 0.727 ± 0.518 | 0.023 |
Positive | 168 | 531 ± 346 | 1.127 ± 1.184 |
*P values are from Mann-Whitney or Kruskal-Wallis test. The P values <0.05 are in bold, indicating significance; the P values >0.05, but <0.15 are in italic, indicating weak significance.